A new statistical diagnostic tool for respiratory diseases

M. Wiegand (Cambridge/ Manchester, United Kingdom), S. Nadarajah (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), K. Holt (Manchester, United Kingdom), K. Mcguinness (Manchester, United Kingdom)

Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care
Session: New and integrated tools for respiratory diagnosis and care
Session type: Oral Presentation
Number: 3819
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wiegand (Cambridge/ Manchester, United Kingdom), S. Nadarajah (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), K. Holt (Manchester, United Kingdom), K. Mcguinness (Manchester, United Kingdom). A new statistical diagnostic tool for respiratory diseases. 3819

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

A web-based diagnostic tool for chronic cough within the community
Source: Eur Respir J 2006; 28: Suppl. 50, 437s
Year: 2006

Fine crackles quantitative value can help the diagnosis of interstitial lung diseases – Clinical utility of the innovative analyzing system of respiratory sounds
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019

Biomarker-guided design to test clinical proof of concept in allergic respiratory diseases of UR-63325, a new H4R antagonist
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010

New uses of data: from big data to artificial intelligence and clinical decision tools  in children with respiratory diseases
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017


Applying clinical metagenomics for the detection and characterisation of respiratory infections
Source: Eur Respir Monogr 2019; 83: 35-49
Year: 2019


Diagnostic performance of routine objective tests and cost-effective approach for chronic cough
Source: Eur Respir J 2004; 24: Suppl. 48, 537s
Year: 2004

Application of text analytics for identification of respiratory diseases in medical claims
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Novel diagnostic tools and interventions for COPD locomotor and respiratory muscle dysfunction 
Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies
Year: 2017


Advances in diagnostic tools for lower respiratory tract infections
Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era
Year: 2021


Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Phospholipids qualitative analysis: A new diagnostic tool to characterize ABCA3-Associated disease and guide genetic analysis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010

A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012

Exercise on how to include the new rapid methods into diagnostic algorithms
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012

Development of a diagnostic decision tree for obstructive pulmonary diseases based on real-life data
Source: ERJ Open Res 2016
Year: 2016



Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


Hypoventilation during sleep: risk factors, diagnostic algorithms and therapeutic approaches
Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more
Year: 2019


Recognition of the respiratory pathology by statistic methods
Source: Eur Respir J 2001; 18: Suppl. 33, 240s
Year: 2001

Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies
Source: Guideline 1997
Year: 1997